<?xml version="1.0" encoding="UTF-8"?>
<p>China is one of the 22 countries characterized as having a severe TB epidemic, ranking the second after India. There are 1.3 million patients diagnosed with a TB infection, comprising up to 14.3% of the global incidence and 80% of which are from rural areas, especially the northwest part of China where the economy is least developed [
 <xref ref-type="bibr" rid="CR29">29</xref>]. The MDR-TB epidemic in China is very severe and accounts for 1/4â€“1/3 of the global incidence and is listed by WHO as one of the countries/regions requiring special attention [
 <xref ref-type="bibr" rid="CR30">30</xref>]. All drugs available for MDR or XDR TB (extensively drug-resistant tuberculosis) are brand drugs manufactured by the big pharmaceutical companies in developed countries.
</p>
